|
인쇄하기
취소
|
11 drug companies to penalize on labelling violation.
Published: 2001-12-28 06:57:00
Updated: 2001-12-28 06:57:00
11 drug companies may be penalized by an administrative measure on account of labelling and product quality problems.
The KFDA reported that Voltaren tab. (Norvatis Korea), Tamoxen tab. (Korea United Pharm. Co.) and Baccidal cap. (Chongkundang) be suspended to sell for 15 days due to no compliance to the official instruction of the label correction.
Geumbichun granule (Bomoon Pharm. Co.)...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.